Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Avalon GloboCare Corp. (CHGA : NSDQ)

• Company Description    Avalon GloboCare Corp. is a clinical-stage biotechnology company. It involved in developing and delivering innovative, transformative cellular therapeutics, precision diagnostics and clinical laboratory services. Avalon GloboCare Corp. is based in FREEHOLD, N.J. Number of Employees: 2

• Price / Volume Information    Yesterday's Closing Price: $0.24 Daily Weekly Monthly 20 Day Moving Average: 3,211,929 shares Shares Outstanding: 14.53 (millions) Market Capitalization: $3.42 (millions) Beta: -0.03 52 Week High: $2.97 52 Week Low: $0.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -21.50% -22.08% 12 Week -41.94% -43.53% Year To Date -80.37% -80.76%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4400 ROUTE 9 SOUTH SUITE 3100 - FREEHOLD,NJ 07728 USA ph: 732-780-4400 fax: 732-780-5600 avco@crescendo-ir.com http://www.avalon-globocare.com

• General Corporate Information    Officers Meng Li - Chief Executive Officer Wenzhao Lu - Chairman Luisa Ingargiola - Chief Financial Officer Steven A. Sanders - Director Lourdes Felix - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 05344R302 SIC: 7371 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 14.53 Most Recent Split Date: 10.00 (0.07:1) Beta: -0.03 Market Capitalization: $3.42 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 65.73% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 1.45% vs. Previous Quarter: 0.00% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - -74.36 12/31/25 - -66.46 Current Ratio 06/30/26 - - 03/31/26 - 0.38 12/31/25 - 0.11 Quick Ratio 06/30/26 - - 03/31/26 - 0.38 12/31/25 - 0.11 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - -1.81 12/31/25 - -3.77 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©